TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28681717

Group type: COMPARATOR
Intervention: Guided self-help
Number of subjects: 475

Group type: COMPARATOR
Intervention: Supported cCBT
Number of subjects: 475

Group type: COMPARATOR
Intervention: Guided self-help and supported cCBT
Number of subjects: 475

Group type: COMPARATOR
Intervention: Qualitative interviews
Number of subjects: 475
Study: 26407689

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (non-obese patients)
Number of subjects: 40
Study: 24176459

Group type: EXPERIMENTAL
Intervention: CTAS 5 patients admitted to hospital
Number of subjects: 37416

Group type: EXPERIMENTAL
Intervention: Age over 65
Number of subjects: 37416

Group type: EXPERIMENTAL
Intervention: Arrival by ambulance
Number of subjects: 37416
Study: 21955733

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 μg daily
Number of subjects: 5993

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 5993
Study: 18196610

Group type: EXPERIMENTAL
Intervention: SMS text messaging reminder
Number of subjects: 1848

Group type: EXPERIMENTAL
Intervention: Telephone reminder
Number of subjects: 1848

Group type: COMPARATOR
Intervention: Control (no reminder)
Number of subjects: 1848

Group type: EXPERIMENTAL
Intervention: Cost per attendance for SMS
Number of subjects: 1848

Group type: EXPERIMENTAL
Intervention: Cost per attendance for telephone
Number of subjects: 1848
Study: 16310902

Group type: EXPERIMENTAL
Intervention: Intramuscular revaccination (10 microg per dose)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intradermal revaccination (2 microg per dose)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Booster dose (5 microg) for those who lost seroprotection
Number of subjects: 40
Study: 15115101

Group type: EXPERIMENTAL
Intervention: DTPa vaccine
Number of subjects: 180

Group type: COMPARATOR
Intervention: DTPw vaccine
Number of subjects: 180
Study: 10907947

Group type: COMPARATOR
Intervention: 5-fluorouracil (450 mg/m2 i.v. weekly) and levamisole (150 mg p.o. every two weeks)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Leucovorin (20 mg/m2 i.v.), 5-fluorouracil and levamisole
Number of subjects: 500
Study: 9362435

Group type: EXPERIMENTAL
Intervention: Clodronate, 300 mg/day intravenously (i.v.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral clodronate, 1600-3200 mg/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Alendronate, 5 mg i.v. as a single infusion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Alendronate, 40 mg orally/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Calcium supplements
Number of subjects: 12
Study: 31340493

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (weight loss, healthy diet, physical activity)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 211
Study: 29189306

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Progressive resisted exercise
Number of subjects: 136

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 136
Study: 27725911

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) with docetaxel (DOC) plus nedaplatin (NDP) followed by IMRT concurrent with weekly NDP
Number of subjects: 223
Study: 24694530

Group type: EXPERIMENTAL
Intervention: IV metoprolol
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control
Number of subjects: 270
Study: 21926660

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Spontaneously Breathing
Number of subjects: 24
Study: 18379260

Group type: EXPERIMENTAL
Intervention: Various interventions studied in randomized controlled trials
Number of subjects: 72
Study: 17063217

Group type: EXPERIMENTAL
Intervention: Mood disorders group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manic episode subgroup
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 12947431

Group type: EXPERIMENTAL
Intervention: 5 g of guar gum (3.6 g galactomannan)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 5 g of fructose
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 5 g of guar gum + 5 g of fructose
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (50 g of available carbohydrate from maltodextrin and white bread)
Number of subjects: 30
Study: 11143452

Group type: EXPERIMENTAL
Intervention: Single-talker sentence lists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mixed-talker sentence lists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-color visual stimuli
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mixed-color visual stimuli
Number of subjects: 0
Study: 9249631

Group type: EXPERIMENTAL
Intervention: Topical metronidazole (95% collagen and 5% metronidazole device) combined with mechanical treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mechanical treatment alone
Number of subjects: 30
Study: 8309665

Group type: EXPERIMENTAL
Intervention: Amnioinfusion with room temperature normal saline (0.9%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amnioinfusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transabdominal amnioinfusion
Number of subjects: 0
Study: 3828955

Group type: EXPERIMENTAL
Intervention: L‐phenylalanine mustard (L‐PAM) and 5‐fluorouracil (5‐FU) with tamoxifen
Number of subjects: 1597

Group type: COMPARATOR
Intervention: L‐phenylalanine mustard (L‐PAM) and 5‐fluorouracil (5‐FU) without tamoxifen
Number of subjects: 1597
Study: 31509842

Group type: EXPERIMENTAL
Intervention: Heidelberg Spectralis II OCT-A with EA-Tool software
Number of subjects: 23
Study: 28778405

Group type: COMPARATOR
Intervention: Permanent running lights on bicycles
Number of subjects: 6800

Group type: COMPARATOR
Intervention: Yellow bicycle jacket
Number of subjects: 6800
Study: 27510539

Group type: EXPERIMENTAL
Intervention: Gene-based personalized nutrition (PN)
Number of subjects: 1466

Group type: COMPARATOR
Intervention: Nongene-based PN (level 2)
Number of subjects: 1466

Group type: COMPARATOR
Intervention: Standard dietary advice (level 0)
Number of subjects: 1466

Group type: EXPERIMENTAL
Intervention: APOE genotype E4+
Number of subjects: 1466
Study: 26576815

Group type: EXPERIMENTAL
Intervention: Klar bleiben intervention (75 classes)
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Control group (75 classes)
Number of subjects: 3000
Study: 23752849

Group type: EXPERIMENTAL
Intervention: Intraoperative ozone and postoperative millimeter wave therapy
Number of subjects: 0
Study: 20801265

Group type: EXPERIMENTAL
Intervention: Virtual myoelectric hand
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Isolated prosthetic hand
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Prosthetic simulator
Number of subjects: 34

Group type: COMPARATOR
Intervention: All training types
Number of subjects: 34
Study: 18752143

Group type: EXPERIMENTAL
Intervention: L‐NMMA
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 16033924

Group type: EXPERIMENTAL
Intervention: Event-related functional magnetic resonance imaging (fMRI)
Number of subjects: 0
Study: 12954574

Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil [450 mg/m(2) intravenous (i.v.) bolus on days 1‐5] and levamisole (150 mg orally for 3 days, every 14 days for 6 months)
Number of subjects: 1703

Group type: COMPARATOR
Intervention: 6‐S‐leucovorin (100 mg/m(2) i.v. bolus on days 1‐5) followed by 5‐fluorouracil (370 mg/m(2) i.v. bolus on days 1‐5), plus levamisole (as arm A), every 4 weeks for six cycles
Number of subjects: 1703
Study: 15505964

Group type: EXPERIMENTAL
Intervention: Phonological awareness program
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Word analogy program
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 9375538

Group type: EXPERIMENTAL
Intervention: Sitting with supported forearms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Using a mouse with supported forearms
Number of subjects: 0
Study: 1347757

Group type: EXPERIMENTAL
Intervention: Lovastatin (20‐80 mg daily)
Number of subjects: 8245

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8245

Group type: EXPERIMENTAL
Intervention: Lovastatin
Number of subjects: 8245
Study: 2863220

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg once a day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nifedipine (10 mg three times a day)
Number of subjects: 21
Study: 31811497

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ibuprofen 600 mg
Number of subjects: 70
Study: 30035578

Group type: EXPERIMENTAL
Intervention: Alcohol targeting a blood alcohol concentration (BAC) of .08 g%
Number of subjects: 447

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 447
Study: 28760209

Group type: EXPERIMENTAL
Intervention: Insertable cardiac monitor (ICM) for continuous arrhythmia monitoring
Number of subjects: 500

Group type: COMPARATOR
Intervention: Standard of care follow-up
Number of subjects: 500
Study: 26206075

Group type: EXPERIMENTAL
Intervention: Attention control training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention bias modification
Number of subjects: 0
Study: 24018099

Group type: EXPERIMENTAL
Intervention: Sentence production task with two objects and a verb, examining four types of disfluency: filled pauses, unfilled pauses, repetitions, and repairs.
Number of subjects: 106
Study: 21153822

Group type: EXPERIMENTAL
Intervention: Zibotentan 10 mg plus pemetrexed 500 mg/m²
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo plus pemetrexed 500 mg/m²
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study: 18297971

Group type: EXPERIMENTAL
Intervention: Magnesium (2 grams)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 104
Study: 16529781

Group type: EXPERIMENTAL
Intervention: 10 degrees C thermal stimulus applied to the tongue
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 22 degrees C thermal stimulus applied to the tongue
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 44 degrees C thermal stimulus applied to the tongue
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Resting temperature of the tongue
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hypothenar of the hand (control site)
Number of subjects: 12
Study: 12957333

Group type: EXPERIMENTAL
Intervention: Coaching by community pharmacists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no coaching)
Number of subjects: 0
Study: 11030858

Group type: EXPERIMENTAL
Intervention: Resuscitation course with didactic lectures and skills practice stations, including a minimum of 3 practice mock resuscitations with immediate feedback throughout postgraduate year 3.
Number of subjects: 58
Study: 9216977

Group type: EXPERIMENTAL
Intervention: PETCO2
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: PJCO2
Number of subjects: 12
Study: 8227863

Group type: EXPERIMENTAL
Intervention: Aqueous beclomethasone dipropionate (168 micrograms twice daily)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (220 micrograms twice daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 12
Study: 3524050

Group type: EXPERIMENTAL
Intervention: Live cold-adapted recombinant bivalent vaccine of influenza type A
Number of subjects: 30000

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30000
Study: 30680521

Group type: EXPERIMENTAL
Intervention: Niraparib 300 mg once daily
Number of subjects: 58
Study: 28148501

Group type: EXPERIMENTAL
Intervention: Enalapril-folic acid (10 mg enalapril and 0.8 mg folic acid)
Number of subjects: 15364

Group type: COMPARATOR
Intervention: Enalapril alone (10 mg enalapril)
Number of subjects: 15364
Study: 26254941

Group type: EXPERIMENTAL
Intervention: Self-Regulation Treatment Group (n = 136)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Self-Efficacy Treatment Group (n = 138)
Number of subjects: 274
Study: 23472068

Group type: EXPERIMENTAL
Intervention: Market priming using phrases related to markets and trade
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified how they were treated)
Number of subjects: 0
Study: 21088912

Group type: EXPERIMENTAL
Intervention: 7-day recall questionnaire
Number of subjects: 140

Group type: COMPARATOR
Intervention: Daily diary for 7 days
Number of subjects: 140
Study: 19719710

Group type: EXPERIMENTAL
Intervention: Custom foot orthoses
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sham insoles
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Custom foot orthoses and Sham insoles
Number of subjects: 61
Study: 17244518

Group type: EXPERIMENTAL
Intervention: Naltrexone 50mg
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 15531696

Group type: EXPERIMENTAL
Intervention: 500 mg Ca/d
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study: 11379850

Group type: EXPERIMENTAL
Intervention: BPRS-A (Brief Psychiatric Rating Scale-Anchored)
Number of subjects: 207
Study: 9757152

Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water
Number of subjects: 10
Study: 8154971

Group type: EXPERIMENTAL
Intervention: Low-dose intravenous ganciclovir for 3 weeks (group 2, n = 24)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Seven doses of intravenous immunoglobulin for 6-week periods (group 1, n = 27)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Historical controls who received renal allografts from CMV-seropositive donors between 1987 and 1989 (group 3, n = 23)
Number of subjects: 51
Study: 3042356

Group type: EXPERIMENTAL
Intervention: urapidil (60 to 120 mg/day)
Number of subjects: 44

Group type: COMPARATOR
Intervention: atenolol (50 to 100 mg/day)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: urapidil
Number of subjects: 44

Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 44
Study: 29489876

Group type: EXPERIMENTAL
Intervention: Probiotic yoghurt
Number of subjects: 14

Group type: COMPARATOR
Intervention: Acidified milk
Number of subjects: 14
Study: 28173897

Group type: EXPERIMENTAL
Intervention: IMB-based pilot intervention
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 68
Study: 26298795

Group type: EXPERIMENTAL
Intervention: Nightly dosing with 10 mg zolpidem (QHS-10)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Nightly dosing with 5 mg zolpidem (QHS-5)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Intermittent dosing with 10 mg zolpidem (IDS-10)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Partial reinforcement dosing with 10 mg zolpidem (PRS-10)
Number of subjects: 74
Study: 23246610

Group type: EXPERIMENTAL
Intervention: Treatment indicated for schizophrenia (specific treatments not detailed in the abstract)
Number of subjects: 18239

Group type: EXPERIMENTAL
Intervention: Recruitment strategies implemented in ZODIAC study
Number of subjects: 18239
Study: 21696871

Group type: EXPERIMENTAL
Intervention: Isometric contractions at 30%, 40%, 50%, and 60% of maximum voluntary contraction
Number of subjects: 20
Study: 18420167

Group type: EXPERIMENTAL
Intervention: Functional dyspepsia (FD) in women
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Functional dyspepsia (FD) in men
Number of subjects: 176
Study: 16930215

Group type: EXPERIMENTAL
Intervention: Alcohol at 0.1% BAL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol at 0.03% BAL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-discontinuation of alcohol at 0.1% BAL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Withdrawal from alcohol at 0.1% BAL
Number of subjects: 0
Study: 12966595

Group type: EXPERIMENTAL
Intervention: Ferrous sulfate 300 mg twice daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 10894865

Group type: EXPERIMENTAL
Intervention: Cisplatin/vincristine/fluorouracil (regimen A)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Cisplatin/continuous infusion doxorubicin (regimen B)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Stage I-UH
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Stage II
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Stage III
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Stage IV
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Stage III or IV disease, tumor-free post-induction surgery I
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Stage III or IV disease, complete resections
Number of subjects: 182
Study: 9410281

Group type: EXPERIMENTAL
Intervention: Bronchodilator inhalation (0.2 mg fenoterol)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (20 healthy subjects)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Patients unresponsive to beta‐agonist (delta FEVI <= 15%)
Number of subjects: 23
Study: 1589588

Group type: EXPERIMENTAL
Intervention: 1.5 mg RS 86 (cholinergic agonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6747142

Group type: EXPERIMENTAL
Intervention: Streptokinase/streptodornase (SK/SD) (100 U of SK per 25 U of SD)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Streptokinase (SK) (375 U)
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Streptokinase/streptodornase (SK/SD)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Streptokinase (SK)
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Recall-antigen battery (SK/SD, SK, Candida, Trichophyton, tetanus toxoid, purified protein derivative, coccidioidin)
Number of subjects: 325
Study: 31144105

Group type: EXPERIMENTAL
Intervention: Survey discussing a female surgeon
Number of subjects: 3128

Group type: COMPARATOR
Intervention: Survey discussing a male surgeon
Number of subjects: 3128
Study: 30303817

Group type: EXPERIMENTAL
Intervention: Pimavanserin 34 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27856202

Group type: EXPERIMENTAL
Intervention: Joint National Committee (JNC) 7 compliant treatment with intensive BP goals (<120/80 mm Hg)
Number of subjects: 123
Study: 25264877

Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Irbesartan (150 mg)
Number of subjects: 12
Study: 19874572

Group type: EXPERIMENTAL
Intervention: Iron supplementation after blood donation
Number of subjects: 399

Group type: COMPARATOR
Intervention: No additional iron after blood donation
Number of subjects: 399
Study: 16386539

Group type: EXPERIMENTAL
Intervention: Cyclosporine (G-1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tacrolimus (G-2)
Number of subjects: 30
Study: 11784408

Group type: EXPERIMENTAL
Intervention: Self-help intervention to promote lower fat and higher fruit and vegetable consumption
Number of subjects: 1205

Group type: COMPARATOR
Intervention: No materials (control group)
Number of subjects: 1205
Study: 9488123

Group type: EXPERIMENTAL
Intervention: 8 Gy as a single fraction
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 16 Gy in four fractions
Number of subjects: 57

Group type: COMPARATOR
Intervention: Both interventions (8 Gy single fraction and 16 Gy in four fractions)
Number of subjects: 57
Study: 7990083

Group type: EXPERIMENTAL
Intervention: Indapamide 1.25 mg/day
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study: 2647556

Group type: EXPERIMENTAL
Intervention: Aspirin alone (330 mg 3 times daily)
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Aspirin plus dipyridamole (75 mg 3 times daily)
Number of subjects: 475

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Insulin-treated patients
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Clinically stable patients
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Deteriorating patients
Number of subjects: 475
Study: 4145234

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Practolol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 29525823

Group type: EXPERIMENTAL
Intervention: Ankaferd blood stopper (ABS)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Feracrylum 1% solution (FS)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 225
Study: 26848715

Group type: EXPERIMENTAL
Intervention: Maternal micronutrient supplementation
Number of subjects: 1412

Group type: EXPERIMENTAL
Intervention: Ultrasound measures below the 10th percentile
Number of subjects: 1412
Study: 24786017

Group type: EXPERIMENTAL
Intervention: Sildenafil fine granule 50 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sildenafil tablet 50 mg
Number of subjects: 40
Study: 22941691

Group type: EXPERIMENTAL
Intervention: Domestic biofragmentable anastomotic ring (BAR)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Valtrac BAR (Control)
Number of subjects: 134
Study: 19948079

Group type: EXPERIMENTAL
Intervention: Diet enriched with fish and olive oils (UFA)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control diet (CON)
Number of subjects: 16
Study: 18333865

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (960 mg b.i.d.; 160 mg trimethoprim and 800 mg sulfamethoxazole)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Tenofovir (300 mg q.d.)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Maraviroc plus placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Maraviroc plus cotrimoxazole
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Maraviroc plus tenofovir
Number of subjects: 28
Study: 15940615

Group type: EXPERIMENTAL
Intervention: Infliximab 4-5 mg/kg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 12915643

Group type: EXPERIMENTAL
Intervention: Testosterone treatment (500 mg, 250 mg, and 250 mg im testosterone esters)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (matching oil-based placebo)
Number of subjects: 17
Study: 10562588

Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 106

Group type: COMPARATOR
Intervention: Laparoscopic sterilisation (Control)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Cholecystectomy (Men)
Number of subjects: 106
Study: 8912039

Group type: EXPERIMENTAL
Intervention: Negative mood induction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral mood induction
Number of subjects: 0